Results 201 to 210 of about 14,868 (228)

A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study

Pediatric Blood and Cancer, 2021
Brian Weiss, Gregory A Yanik, Arlene Naranjo   +2 more
exaly  

[131I]MIBG and topotecan: A rationale for combination therapy for neuroblastoma

Cancer Letters, 2005
Marie Boyd, Mark N Gaze
exaly  

¹³¹ I‐MIBG and phaeochromocytoma

Medical Journal of Australia, 1985
openaire   +2 more sources

Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)

European Journal of Cancer, 2015
Judith G Villablanca, Gregory A Yanik, Katherine K Matthay   +2 more
exaly  

123I-MIBG scintigraphy/SPECT versus 18F-FDG PET in paediatric neuroblastoma

European Journal of Nuclear Medicine and Molecular Imaging, 2011
Michael Albert
exaly  

Decreased myocardial 123 I-MIBG uptake in Parkinson's disease

Acta Neurologica Scandinavica, 1998
Hiroaki Yoshikawa
exaly  

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

Pediatric Blood and Cancer, 2017
Steven G Dubois, Rajen J Mody, Arlene Naranjo   +2 more
exaly  

Editorial: MIBG conference

Medical and Pediatric Oncology, 1987
openaire   +1 more source

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

Movement Disorders, 2003
Frédéric Courbon, Christine Brefel-Courbon, Claire Thalamas   +2 more
exaly  

131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

European Journal of Nuclear Medicine and Molecular Imaging, 2010
Francesco Giammarile, Cumali Aktolun, Lorenzo Stefano Maffioli   +2 more
exaly